Related Experiment Video
Updated: Feb 7, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes
Raffaella Sabatino1, Serafina Battistelli2, Mauro Magnani1
1Department of Biomolecular Sciences, Section of Biochemistry and Molecular Biology, University of Urbino "Carlo Bo", via A. Saffi 2, 61029, Urbino, PU, Italy.
Abstract:
In tumor microenvironment, tumor-associated macrophages (TAMs) are implicated in cancer sustainment, metastasis, and drug resistance, raising a growing interest as targets in cancer therapy. Since the bisphosphonate zoledronate has proven to affect TAMs' functions, the anti-tumor effect of single or repeated administrations of red blood cells (RBCs) encapsulating zoledronate was evaluated in a mouse model of mammary carcinoma. The obtained results showed that loaded RBCs, but not free zoledronate, caused a significant (p < 0.01) and time-lasting reduction of TAMs' extent in tumor mass of Balb/C mice inoculated with murine mammary carcinoma T41 cells; in addition, a significant reduction (p < 0.05) of tumor growth rate has been obtained only following repeated administrations of zoledronate-loaded RBCs. The anti-tumor effect was secondary to the early depletion of spleen macrophages. Moreover, by assessing the IgG2a/IgG1 ratio, a prevalence of Th1 cytotoxic response in tumor-bearing mice receiving zoledronate by means of RBCs has been observed. These encouraging findings provide further evidence for the central role played by macrophages in tumor setting and highlight the suitability of zoledronate-loaded RBCs as pharmacological agents in depleting, even if indirectly, TAMs and, thus, their eligibility as part of a therapeutic strategy in cancer treatment.
Insights
Zoledronate-loaded red blood cells (RBCs) effectively reduce tumor-associated macrophages (TAMs) and inhibit tumor growth in mice. This RBC-based drug delivery system shows promise for cancer therapy by targeting TAMs.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Tumor-associated macrophages (TAMs) play a crucial role in promoting tumor growth, metastasis, and drug resistance.
- Targeting TAMs is a promising strategy for cancer therapy.
- Zoledronate, a bisphosphonate, has demonstrated effects on TAM functions.
Purpose of the Study:
- To evaluate the anti-tumor effects of zoledronate encapsulated in red blood cells (RBCs).
- To investigate the impact of single and repeated administrations of zoledronate-loaded RBCs on TAMs and tumor growth in a murine mammary carcinoma model.
Main Methods:
- Administration of zoledronate-loaded RBCs and free zoledronate to mice with mammary carcinoma.
- Quantification of TAMs in tumor mass.
- Assessment of tumor growth rate.
- Evaluation of spleen macrophage depletion.
- Analysis of Th1 cytotoxic response via IgG2a/IgG1 ratio.
Main Results:
- Zoledronate-loaded RBCs significantly reduced TAMs in the tumor microenvironment, unlike free zoledronate.
- Repeated administration of zoledronate-loaded RBCs significantly reduced tumor growth rate.
- The anti-tumor effect was associated with early depletion of spleen macrophages.
- A Th1-biased cytotoxic response was observed in mice treated with zoledronate-loaded RBCs.
Conclusions:
- Zoledronate-loaded RBCs are effective in reducing TAMs and inhibiting tumor growth.
- This drug delivery system shows potential as a therapeutic strategy for cancer by indirectly depleting TAMs.
- The findings underscore the importance of macrophages in cancer progression and highlight the suitability of zoledronate-loaded RBCs for cancer treatment.
Related Concept Videos
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Structure and Function of Erythrocytes
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
Preclinical Development: Overview
Impact Loading
In cases of elastic deformation,...
Self-Evaluation: Self-Enhancement and Self-Verification

